CELLDEX THERAPEUTICS INC (CLDX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CLDX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CLDX | Director | 64 | ["B.S. degree in biology from Long Island University","M.D. from the State University of New York at Stony Brook School of Medicine","Executive Vice President and Chief Medical Officer at ChemoCentryx, Inc. from 2021 to 2022","Chief Medical Officer at Immunovant, Inc. in 2021","Chief Executive Officer at Heartwood Biopharma Group from August 2021 until December 2023","Senior Vice President and Chief Medical Officer at Akebia Therapeutics, Inc. from 2017 to 2019","Vice President in Clinical Development at AbbVie Inc. from 2013 to 2016"] | ["Nominating and Corporate Governance","Science and Commercialization"] | 2026 |
Biography sourced from the proxy statement filing.
RITA I. JAIN, M.D., 64
CARIEER HIGHLIGHTS
Director since February 2023
AnaptysBio, Inc.*
Board of directors since April 2023
PUBLIC BOARDS: 4
Avalo Therapeutics, Inc.*
Board of directors since June 2025
COMMITTEES: Nominating and Corporate Governance, Science and Commercialization
SAB Biotherapeutics, Inc.*
Board of directors since January 2026
EDUCATION: B.S. degree in biology from Long Island University, and her M.D. from the State University of New York at Stony Brook School of Medicine
Provention Bio, Inc.
Board of Directors from January 2023 until its acquisition by Sanofi in April 2023
AM-Pharma B.V.
Supervisory Board from 2020 until 2023
ChemoCentryx, Inc.
Board of Directors from 2019 until its acquisition by Amgen in 2022
Executive Vice President and Chief Medical Officer from 2021 to 2022
Immunovant, Inc.
Chief Medical Officer in 2021
Heartwood Biopharma Group
Chief Executive Officer from August 2021 until December 2023
Akebia Therapeutics, Inc.
Senior Vice President and Chief Medical Officer from 2017 to 2019
AbbVie Inc.
Vice President in Clinical Development from 2013 to 2016, including Men's and Women's Health and Metabolic Development
Abbott Laboratories
Various leadership roles from 2003 through 2012, including as Divisional Vice President of Pain, Respiratory and Metabolic Disease Development